The test, developed by Australian Digital Diagnostics company Ellume, does not require a sample to be sent to the lab, like home pregnancy tests.
This Covid-19 home test, called Ellume, is an antigen test designed to detect pieces of viral proteins that trigger an immune response in the body.
According to the manufacturer, the results of this home experiment will be presented through a smartphone application in less than 20 minutes.
The experiment involves collecting a sample with a nasal swap, which users then place in a Bluetooth-enabled analytics that is synchronized with a smartphone app.
According to the company, the results will be presented through this program and can be shared with healthcare professionals.
The company said it expects to produce more than three million copies of the test in January (January to February) at a potential cost of $ 30 or less.
The company announced in an e-mail to NBC News that the Covid-19 home test will be available in pharmacies and online.